The presidents of about 30 large pharmaceuticals sent a warning letter to Brussels, demanding certain conditions to prevent investors from leaving the industry to the US in a climate of trade war. In a letter addressed on April 11th to the President of the European Commission Ursula von der Layen, the heads of 32, large and medium -sized pharmaceutical companies, promise to increase the share of the European market today representing 22.7% in worldwide sales. Without them, “in three months from today, scheduled investments of € 16.5 billion could be transferred outside Europe,” warned NOVO NORDISK, PFIZER, ELI LILLY, ROCHE, SANOFI, MERK, GSK and SERVIER in the letter this letter published by many media and which came to the media today. Companies are calling for a competitive European market “that attracts, correctly evaluates and rewards innovation”, considering that continuing commercial tensions will further accelerate investment reduction […]
Source: News Beast
With 6 years of experience, I bring to the table captivating and informative writing in the world news category. My expertise covers a range of industries, including tourism, technology, forex and stocks. From brief social media posts to in-depth articles, I am dedicated to creating compelling content for various platforms.
